Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Codon optimization of human factor VIII cDNAs leads to high-level expression

Natalie J. Ward, Suzanne M. K. Buckley, Simon N. Waddington, Thierry VandenDriessche, Marinee K. L. Chuah, Amit C. Nathwani, Jenny McIntosh, Edward G. D. Tuddenham, Christine Kinnon, Adrian J. Thrasher, John H. McVey

Blood (2011) 117 (3): 798–807.

https://doi.org/10.1182/blood-2010-05-282707

Published: 2011

Includes: Supplemental data

Journal Articles

Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells

Thierry VandenDriessche, Zoltán Ivics, Zsuzsanna Izsvák, Marinee K. L. Chuah

Blood (2009) 114 (8): 1461–1468.

https://doi.org/10.1182/blood-2009-04-210427

Published: 2009

Journal Articles

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

Marinee K. L. Chuah, Gudrun Schiedner, Lieven Thorrez, Brian Brown, Marion Johnston, Veerle Gillijns, Sabine Hertel, Nico Van Rooijen, David Lillicrap, Désiré Collen, Thierry VandenDriessche, Stefan Kochanek

Blood (2003) 101 (5): 1734–1743.

https://doi.org/10.1182/blood-2002-03-0823

Published: 2003

Journal Articles

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

Thierry VandenDriessche, Lieven Thorrez, Luigi Naldini, Antonia Follenzi, Lieve Moons, Zwi Berneman, Desire Collen, Marinee K. L. Chuah

Blood (2002) 100 (3): 813–822.

https://doi.org/10.1182/blood.V100.3.813

Published: 2002

Journal Articles

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

Marc Jacquemin, Renaud Lavend'homme, Abdellah Benhida, Beatrijs Vanzieleghem, Roseline d'Oiron, Jean-Maurice Lavergne, Hans H. Brackmann, Rainer Schwaab, Thierry VandenDriessche, Marinee K. L. Chuah, Marc Hoylaerts, Jean Guy G. Gilles, Kathelijne Peerlinck, Jos Vermylen, Jean-Marie R. Saint-Remy

Blood (2000) 96 (3): 958–965.

https://doi.org/10.1182/blood.V96.3.958

Published: 2000

NARROW

Codon optimization of human factor VIII cDNAs leads to high-level expression

Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

Email alerts

ASH Publications

American Society of Hematology

Codon optimization of human factor VIII cDNAs leads to high-level expression

Emerging potential of transposons for gene therapy and generation of induced pluripotent stem cells

Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors

Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo

A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only